Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Acasti Pharma Inc. logo

Acasti Pharma Inc.

Sector: Healthcare   

Industry: Biotechnology

Optionable: No  Market Cap: 29 M  90-day average vol: 29,347

Previous close: 3.365  Open: 3.33  Bid: 3.1  Ask: 3.5
52 week range    
Last updated: Monday 26th February 2024
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


ACST Cash Flow

Invalid dateMar-20Mar-21Mar-22Mar-23
(Increase) Decrease in other current assets-225000.025000.0
(Increase) Decrease in other working capital7000.0-7 M
(Increase) Decrease in payables-3 M-7 M-2 M411000.0
(Increase) Decrease in receivables581000.058000.0-18000.0-302000.0
Amortization of intangibles2 M781000.0
AssetImpairmentCharge6 M249000.034 M
Cash at beginning of period-15 M14 M51 M30 M
Cash at end of period-17 M51 M30 M28 M
Cash flow-23 M-14 M-17 M-16 M
CashFlowFromContinuingInvestingActivities8 M-10 M-4 M13 M
ChangeInAccountPayable-3 M-2 M411000.0
ChangeInPayablesAndAccruedExpense-3 M-7 M-2 M411000.0
ChangeInWorkingCapital-3 M-6 M-3 M181000.0
Current deferred income taxes-648000.0-10 M
Deferred income taxes-648000.0-10 M
Depreciation unreconciled2 M924000.0124000.0
DepreciationAndAmortization2 M924000.0124000.0
Effect of exchange rate changes-1 M1 M26000.0-8000.0
FinancingCashFlow13 M59 M304000.0
Free cash flow-23 M-14 M-17 M-16 M
GainLossOnInvestmentSecurities1 M2 M
Issuance of capital stock7 M59 M304000.0
Issuance of debt-2 M
IssuanceOfCapitalStock7 M59 M304000.0
IssuanceOfDebt-2 M
Net cash from financing activities13 M59 M304000.0
Net cash from investing activities8 M-10 M-4 M13 M
Net cash from operating activities-23 M-14 M-17 M-16 M
Net change in cash & cash equivalents-3 M37 M-21 M-2 M
Net income from continuing operations-26 M-20 M-10 M-42 M
NetCommonStockIssuance7 M59 M304000.0
NetInvestmentPropertiesPurchaseAndSale8 M-10 M-4 M13 M
NetInvestmentPurchaseAndSale8 M-10 M-4 M13 M
NetIssuancePaymentsOfDebt-2 M
NetLongTermDebtIssuance-2 M
Operating (gains) losses246000.0814000.0-370000.05000.0
Other financing charges net7000.0-143000.0
Other non-cash items3 M10 M-4 M36 M
ProceedsFromIssuanceOfWarrants8 M183000.0
Purchase of Float term investments-2 M-10 M-35 M-5 M
PurchaseOfInvestment-2 M-10 M-35 M-5 M
Repayment of debt-2 M
RepaymentOfDebt-2 M
Revenue per share2 M781000.0
Sale of short term investments10 M21000.031 M18 M
SaleOfInvestment10 M21000.031 M18 M
ShortTermDebtPayments-2 M
StockBasedCompensation2 M1 M1 M2 M
UnrealizedGainLossOnInvestmentSecurities1 M2 M-5 M-10000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University